Roland Martin

Cited by

	All	Since 2020
Citations	45858	11476
h-index	101	45
i10-index	342	177

2600

1300

650

1950

199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025196 183 261 373 491 679 830 720 946 899 911 1078 1289 1260 1429 1509 1402 1554 1553 1807 2081 2072 2142 2111 2050 1842 2052 2159 2517 2322 2127 2111 225

Public access

View all

95 articles

5 articles

available

not available

Based on funding mandates

Co-authors

Bruno GranConsultant Neurologist and Honorary Professor of Neurology - NUH NHS TrustVerified email at nuh.nhs.uk
Xavier MontalbanVerified email at cem-cat.org
Richard SimonR Simon Consulting, Formerly Chief, Computational & Systems Biology, National Cancer InstituteVerified email at mail.nih.gov
Jan D. LunemannUniversity of ZurichVerified email at uzh.ch
Yingdong ZhaoNational Cancer InstituteVerified email at mail.nih.gov
Christian MünzInstitute of Experimental Immunology, University of ZurichVerified email at immunology.uzh.ch
lawrence steinmanstanford universityVerified email at stanford.edu
Friedemann PaulProfessor für klinische Neuroimmunologie, Charité Universitätsmedizin BerlinVerified email at charite.de
Eric O. LongNational Institute of Allergy and Infectious DiseasesVerified email at nih.gov
Nadja KadomEmory University and Children's of AtlantaVerified email at emory.edu
Jordi RioServicio de Neurologia-Neuroinmunologia. Centro de esclerosis múltiple de Catalunya. Hospital Universitario Vall d'HebronVerified email at cem-cat.org
Maria Pia SormaniUniversity of GenoaVerified email at unige.it
Marco PrinzProfessor of Neuropathology, University Hospital FreiburgVerified email at uniklinik-freiburg.de
Claude C BernardEmeritus Professor, Australian Regenerative Medicine Institute, Monash University, MelbourneVerified email at monash.edu
Alexander U. BrandtEli Lilly and CompanyVerified email at lilly.com
Paul S AlbertNational Cancer InstituteVerified email at mail.nih.gov
Michael RackeProfessor of Neurology, Ohio State UniversityVerified email at osumc.edu
Axel PetzoldUCL, The National Hospital for Neurology and Neurosurgery & Moorfields Eye HospitalVerified email at ucl.ac.uk
Jose Carlos Alvarez-CermeñoRamón y Cajal Research Institute. Madrid. SpainVerified email at salud.madrid.org
Rosina GironesUniversitat de BarcelonaVerified email at ub.edu

Roland Martin

University Zurich

Verified email at usz.ch

multiple sclerosis cellular immunology neuroimmunology T lymphocytes neurology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 (7359), 214-219, 2011	3099	2011
Immunology of multiple sclerosis M Sospedra, R Martin Annu. Rev. Immunol. 23 (1), 683-747, 2005	3039	2005
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis International IBD Genetics Consortium (IIBDGC), C Agliardi, L Alfredsson, ... Nature genetics 45 (11), 1353-1360, 2013	1383	2013
Immunological aspects of demyelinating diseases R Martin, HF McFarland, DE McFarlin Annual review of immunology 10 (1), 153-187, 1992	1353	1992
Multiple sclerosis: a complicated picture of autoimmunity HF McFarland, R Martin Nature immunology 8 (9), 913-919, 2007	1349	2007
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility International Multiple Sclerosis Genetics Consortium*†, ANZgene, ... Science 365 (6460), eaav7188, 2019	1072	2019
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand B Bielekova, B Goodwin, N Richert, I Cortese, T Kondo, G Afshar, B Gran, ... Nature medicine 6 (10), 1167-1175, 2000	1002	2000
Regulatory CD56bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis B Bielekova, M Catalfamo, S Reichert-Scrivner, A Packer, M Cerna, ... Proceedings of the National Academy of Sciences 103 (15), 5941-5946, 2006	738	2006
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis R Martin, HF McFarland, JM Boggs Critical reviews in clinical laboratory sciences 32 (2), 121-182, 1995	688	1995
The OSCAR-IB consensus criteria for retinal OCT quality assessment P Tewarie, L Balk, F Costello, A Green, R Martin, S Schippling, A Petzold PloS one 7 (4), e34823, 2012	586	2012
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways I Štefanová, B Hemmer, M Vergelli, R Martin, WE Biddison, RN Germain Nature immunology 4 (3), 248-254, 2003	577	2003
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients PA Muraro, DC Douek, A Packer, K Chung, FJ Guenaga, ... The Journal of experimental medicine 201 (5), 805-816, 2005	563	2005
Memory B cells activate brain-homing, autoreactive CD4+ T cells in multiple sclerosis I Jelcic, F Al Nimer, J Wang, V Lentsch, R Planas, I Jelcic, A Madjovski, ... Cell 175 (1), 85-100. e23, 2018	489	2018
Exploring the origins of grey matter damage in multiple sclerosis M Calabrese, R Magliozzi, O Ciccarelli, JJG Geurts, R Reynolds, R Martin Nature Reviews Neuroscience 16 (3), 147-158, 2015	469	2015
Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis HF McFarland, JA Frank, PS Albert, ME Smith, R Martin, JO Harris, ... Annals of neurology 32 (6), 758-766, 1992	454	1992
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system M Prinz, H Schmidt, A Mildner, KP Knobeloch, UK Hanisch, J Raasch, ... Immunity 28 (5), 675-686, 2008	450	2008
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis N Sommer, PA Löschmann, GH Northoff, M Weller, A Steinbrecher, ... Nature medicine 1 (3), 244-248, 1995	438	1995
Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein S Brocke, K Gijbels, M Allegretta, I Ferber, C Piercy, T Blankensteini, ... Nature 379 (6563), 343-346, 1996	436	1996
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. R Martin, D Jaraquemada, M Flerlage, J Richert, J Whitaker, EO Long, ... Journal of immunology (Baltimore, Md.: 1950) 145 (2), 540-548, 1990	435	1990
Development of biomarkers in multiple sclerosis B Bielekova, R Martin Brain 127 (7), 1463-1478, 2004	411	2004

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors